Phthalates and Endocrine Disruptors: Implications for Public Health and Regulatory Challenges

Endocrine-disrupting chemicals (EDCs) are pervasive in consumer products, including plastics and personal care items. Phthalates, as a major subclass of EDCs, are especially concerning due to their widespread use and potential for adverse health effects. This paper examines the impacts of phthalates and other EDCs on developmental, reproductive, and neurological health. Epidemiological evidence is reviewed, highlighting heightened risks for vulnerable populations such as women and children. The analysis explores regulatory responses and public advocacy efforts, identifying both successes and ongoing challenges in minimizing exposure. Economic implications and the historical context of regulation are discussed, underscoring the complex interplay between public health, industry interests, and policy. The paper concludes by emphasizing the critical role of public advocacy in driving regulatory change and promoting safer alternatives. Recommendations are provided for future research, policy development, and community engagement to reduce risks associated with EDCs.